AMK, an active metabolite of melatonin, forms via AFMK metabolism and demonstrates potent antioxidant properties. It scavenges singlet oxygen, inhibits PGE2 and PGD2 production, reduces COX-2 levels, and mitigates lipid peroxidation in Parkinson's disease models.
Usually ships within 24 hours.